Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE Registry.

Billings CG, Lewis R, Hurdman JA, Condliffe R, Elliot CA, Thompson AAR, Smith IA, Austin M, Armstrong IJ, Hamilton N, Charalampopoulos A, Sabroe I, Swift AJ, Rothman AM, Wild JM, Lawrie A, Waterhouse JC, Kiely DG.

Pulm Circ. 2019 Apr-Jun;9(2):2045894019848649. doi: 10.1177/2045894019848649.

2.

Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysis.

Sofianopoulou E, Kaptoge S, Gräf S, Hadinnapola C, Treacy CM, Church C, Coghlan G, Gibbs JSR, Haimel M, Howard LS, Johnson M, Kiely DG, Lawrie A, Lordan J, MacKenzie Ross RV, Martin JM, Moledina S, Newnham M, Peacock AJ, Price LC, Rhodes CJ, Suntharalingam J, Swietlik EM, Toshner MR, Wharton J, Wilkins MR, Wort SJ, Pepke-Zaba J, Condliffe R, Corris PA, Di Angelantonio E, Provencher S, Morrell NW.

Eur Respir J. 2019 May 30;53(5). pii: 1801429. doi: 10.1183/13993003.01429-2018. Print 2019 May.

PMID:
30923185
3.

Discovery of Distinct Immune Phenotypes Using Machine Learning in Pulmonary Arterial Hypertension.

Sweatt AJ, Hedlin HK, Balasubramanian V, Hsi A, Blum LK, Robinson WH, Haddad F, Hickey PM, Condliffe R, Lawrie A, Nicolls MR, Rabinovitch M, Khatri P, Zamanian RT.

Circ Res. 2019 Mar 15;124(6):904-919. doi: 10.1161/CIRCRESAHA.118.313911.

PMID:
30661465
4.

Decision-making in pulmonary endarterectomy surgery.

Condliffe R, Quadery SR, Jenkins DP, Armstrong IJ, Kiely DG.

Eur Respir J. 2019 Jan 10;53(1). pii: 1801973. doi: 10.1183/13993003.01973-2018. Print 2019 Jan. No abstract available.

PMID:
30630852
5.

Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.

Rhodes CJ, Batai K, Bleda M, Haimel M, Southgate L, Germain M, Pauciulo MW, Hadinnapola C, Aman J, Girerd B, Arora A, Knight J, Hanscombe KB, Karnes JH, Kaakinen M, Gall H, Ulrich A, Harbaum L, Cebola I, Ferrer J, Lutz K, Swietlik EM, Ahmad F, Amouyel P, Archer SL, Argula R, Austin ED, Badesch D, Bakshi S, Barnett C, Benza R, Bhatt N, Bogaard HJ, Burger CD, Chakinala M, Church C, Coghlan JG, Condliffe R, Corris PA, Danesino C, Debette S, Elliott CG, Elwing J, Eyries M, Fortin T, Franke A, Frantz RP, Frost A, Garcia JGN, Ghio S, Ghofrani HA, Gibbs JSR, Harley J, He H, Hill NS, Hirsch R, Houweling AC, Howard LS, Ivy D, Kiely DG, Klinger J, Kovacs G, Lahm T, Laudes M, Machado RD, MacKenzie Ross RV, Marsolo K, Martin LJ, Moledina S, Montani D, Nathan SD, Newnham M, Olschewski A, Olschewski H, Oudiz RJ, Ouwehand WH, Peacock AJ, Pepke-Zaba J, Rehman Z, Robbins I, Roden DM, Rosenzweig EB, Saydain G, Scelsi L, Schilz R, Seeger W, Shaffer CM, Simms RW, Simon M, Sitbon O, Suntharalingam J, Tang H, Tchourbanov AY, Thenappan T, Torres F, Toshner MR, Treacy CM, Vonk Noordegraaf A, Waisfisz Q, Walsworth AK, Walter RE, Wharton J, White RJ, Wilt J, Wort SJ, Yung D, Lawrie A, Humbert M, Soubrier F, Trégouët DA, Prokopenko I, Kittles R, Gräf S, Nichols WC, Trembath RC, Desai AA, Morrell NW, Wilkins MR; UK NIHR BioResource Rare Diseases Consortium; UK PAH Cohort Study Consortium; US PAH Biobank Consortium.

Lancet Respir Med. 2019 Mar;7(3):227-238. doi: 10.1016/S2213-2600(18)30409-0. Epub 2018 Dec 5.

6.

Diagnostic and prognostic significance of cardiovascular magnetic resonance native myocardial T1 mapping in patients with pulmonary hypertension.

Saunders LC, Johns CS, Stewart NJ, Oram CJE, Capener DA, Puntmann VO, Elliot CA, Condliffe RC, Kiely DG, Graves MJ, Wild JM, Swift AJ.

J Cardiovasc Magn Reson. 2018 Dec 3;20(1):78. doi: 10.1186/s12968-018-0501-8.

7.

Echocardiographic Screening for Pulmonary Hypertension in Congenital Heart Disease: JACC Review Topic of the Week.

Dimopoulos K, Condliffe R, Tulloh RMR, Clift P, Alonso-Gonzalez R, Bedair R, Chung NAY, Coghlan G, Fitzsimmons S, Frigiola A, Howard LS, Jenkins P, Kenny D, Li W, MacDonald ST, McCabe C, Oliver JJ, Spence MS, Szantho GV, von Klemperer K, Wilson DG, Wort SJ; CHAMPION Steering Committee.

J Am Coll Cardiol. 2018 Dec 4;72(22):2778-2788. doi: 10.1016/j.jacc.2018.08.2201. Review.

8.

Diagnosis of Pulmonary Hypertension with Cardiac MRI: Derivation and Validation of Regression Models.

Johns CS, Kiely DG, Rajaram S, Hill C, Thomas S, Karunasaagarar K, Garg P, Hamilton N, Solanki R, Capener DA, Elliot C, Sabroe I, Charalamopopoulos A, Condliffe R, Wild JM, Swift AJ.

Radiology. 2019 Jan;290(1):61-68. doi: 10.1148/radiol.2018180603. Epub 2018 Oct 23.

9.

Management dilemmas in pulmonary arterial hypertension associated with congenital heart disease.

Condliffe R, Clift P, Dimopoulos K, Tulloh RMR.

Pulm Circ. 2018 Jul-Sep;8(3):2045894018792501. doi: 10.1177/2045894018792501. Epub 2018 Jul 23.

10.

The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension.

Quadery SR, Swift AJ, Billings CG, Thompson AAR, Elliot CA, Hurdman J, Charalampopoulos A, Sabroe I, Armstrong IJ, Hamilton N, Sephton P, Garrad S, Pepke-Zaba J, Jenkins DP, Screaton N, Rothman AM, Lawrie A, Cleveland T, Thomas S, Rajaram S, Hill C, Davies C, Johns CS, Wild JM, Condliffe R, Kiely DG.

Eur Respir J. 2018 Sep 16;52(3). pii: 1800589. doi: 10.1183/13993003.00589-2018. Print 2018 Sep.

11.

Incremental Shuttle Walking Test Distance Is Reduced in Patients With Pulmonary Hypertension in World Health Organisation Functional Class I.

Billings CG, Lewis R, Armstrong IJ, Hurdman JA, Smith IA, Austin M, Elliot CA, Charalampopoulos A, Sabroe I, Lawrie A, Thompson AAR, Condliffe R, Kiely DG.

Front Med (Lausanne). 2018 Jun 21;5:172. doi: 10.3389/fmed.2018.00172. eCollection 2018.

12.

Identifying At-Risk Patients with Combined Pre- and Postcapillary Pulmonary Hypertension Using Interventricular Septal Angle at Cardiac MRI.

Johns CS, Wild JM, Rajaram S, Tubman E, Capener D, Elliot C, Condliffe R, Charalampopoulos A, Kiely DG, Swift AJ.

Radiology. 2018 Oct;289(1):61-68. doi: 10.1148/radiol.2018180120. Epub 2018 Jul 3.

13.

British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism.

Howard LS, Barden S, Condliffe R, Connolly V, Davies C, Donaldson J, Everett B, Free C, Horner D, Hunter L, Kaler J, Nelson-Piercy C, O'Dowd E, Patel R, Preston W, Sheares K, Tait C.

BMJ Open Respir Res. 2018 Jun 13;5(1):e000281. doi: 10.1136/bmjresp-2018-000281. eCollection 2018.

14.

Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility.

Chin M, Johns C, Currie BJ, Weatherley N, Hill C, Elliot C, Rajaram S, Wild JM, Condliffe R, Bianchi S, Kiely DG, Swift AJ.

Front Cardiovasc Med. 2018 Jun 8;5:53. doi: 10.3389/fcvm.2018.00053. eCollection 2018.

15.

Circulating Protein Biomarkers in Systemic Sclerosis Related Pulmonary Arterial Hypertension: A Review of Published Data.

Hickey PM, Lawrie A, Condliffe R.

Front Med (Lausanne). 2018 Jun 6;5:175. doi: 10.3389/fmed.2018.00175. eCollection 2018. Review.

16.

Pathophysiology and Diagnosis of Pulmonary Hypertension Due to Left Heart Disease.

Charalampopoulos A, Lewis R, Hickey P, Durrington C, Elliot C, Condliffe R, Sabroe I, Kiely DG.

Front Med (Lausanne). 2018 Jun 6;5:174. doi: 10.3389/fmed.2018.00174. eCollection 2018. Review.

17.

British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism (PE).

Howard LSGE, Barden S, Condliffe R, Connolly V, Davies CWH, Donaldson J, Everett B, Free C, Horner D, Hunter L, Kaler J, Nelson-Piercy C, O-Dowd E, Patel R, Preston W, Sheares K, Campbell T.

Thorax. 2018 Jul;73(Suppl 2):ii1-ii29. doi: 10.1136/thoraxjnl-2018-211539. Epub 2018 Jun 13. Review. No abstract available.

PMID:
29898978
18.

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.

Gräf S, Haimel M, Bleda M, Hadinnapola C, Southgate L, Li W, Hodgson J, Liu B, Salmon RM, Southwood M, Machado RD, Martin JM, Treacy CM, Yates K, Daugherty LC, Shamardina O, Whitehorn D, Holden S, Aldred M, Bogaard HJ, Church C, Coghlan G, Condliffe R, Corris PA, Danesino C, Eyries M, Gall H, Ghio S, Ghofrani HA, Gibbs JSR, Girerd B, Houweling AC, Howard L, Humbert M, Kiely DG, Kovacs G, MacKenzie Ross RV, Moledina S, Montani D, Newnham M, Olschewski A, Olschewski H, Peacock AJ, Pepke-Zaba J, Prokopenko I, Rhodes CJ, Scelsi L, Seeger W, Soubrier F, Stein DF, Suntharalingam J, Swietlik EM, Toshner MR, van Heel DA, Vonk Noordegraaf A, Waisfisz Q, Wharton J, Wort SJ, Ouwehand WH, Soranzo N, Lawrie A, Upton PD, Wilkins MR, Trembath RC, Morrell NW.

Nat Commun. 2018 Apr 12;9(1):1416. doi: 10.1038/s41467-018-03672-4.

19.

Identifying early pulmonary arterial hypertension in patients with systemic sclerosis.

Condliffe R, Kovacs G.

Eur Respir J. 2018 Apr 4;51(4). pii: 1800495. doi: 10.1183/13993003.00495-2018. Print 2018 Apr. No abstract available.

PMID:
29618608
20.

CT derived left atrial size identifies left heart disease in suspected pulmonary hypertension: Derivation and validation of predictive thresholds.

Currie BJ, Johns C, Chin M, Charalampopolous T, Elliot CA, Garg P, Rajaram S, Hill C, Wild JW, Condliffe RA, Kiely DG, Swift AJ.

Int J Cardiol. 2018 Jun 1;260:172-177. doi: 10.1016/j.ijcard.2018.02.114. Epub 2018 Mar 4.

21.

Management of Adults With Congenital Heart Disease and Pulmonary Arterial Hypertension in the UK: Survey of Current Practice, Unmet Needs and Expert Commentary.

Tulloh R, Dimopoulos K, Condliffe R, Clift P; CHAMPION Steering Committee.

Heart Lung Circ. 2018 Aug;27(8):1018-1027. doi: 10.1016/j.hlc.2017.10.018. Epub 2017 Nov 13.

22.

An official European Respiratory Society statement: pulmonary haemodynamics during exercise.

Kovacs G, Herve P, Barbera JA, Chaouat A, Chemla D, Condliffe R, Garcia G, Grünig E, Howard L, Humbert M, Lau E, Laveneziana P, Lewis GD, Naeije R, Peacock A, Rosenkranz S, Saggar R, Ulrich S, Vizza D, Vonk Noordegraaf A, Olschewski H.

Eur Respir J. 2017 Nov 22;50(5). pii: 1700578. doi: 10.1183/13993003.00578-2017. Print 2017 Nov. Erratum in: Eur Respir J. 2018 Jan 18;51(1):.

23.

Non-invasive methods for estimating mPAP in COPD using cardiovascular magnetic resonance imaging.

Johns CS, Rajaram S, Capener DA, Oram C, Elliot C, Condliffe R, Kiely DG, Wild JM, Swift AJ.

Eur Radiol. 2018 Apr;28(4):1438-1448. doi: 10.1007/s00330-017-5143-y. Epub 2017 Nov 16.

24.

British Thoracic Society Clinical Statement on Pulmonary Arteriovenous Malformations.

Shovlin CL, Condliffe R, Donaldson JW, Kiely DG, Wort SJ; British Thoracic Society.

Thorax. 2017 Dec;72(12):1154-1163. doi: 10.1136/thoraxjnl-2017-210764.

25.

Pulmonary arteriovenous malformations emerge from the shadows.

Shovlin CL, Condliffe R, Donaldson JW, Kiely DG, Wort SJ.

Thorax. 2017 Dec;72(12):1071-1073. doi: 10.1136/thoraxjnl-2017-211072. No abstract available.

26.

Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension.

Hadinnapola C, Bleda M, Haimel M, Screaton N, Swift A, Dorfmüller P, Preston SD, Southwood M, Hernandez-Sanchez J, Martin J, Treacy C, Yates K, Bogaard H, Church C, Coghlan G, Condliffe R, Corris PA, Gibbs S, Girerd B, Holden S, Humbert M, Kiely DG, Lawrie A, Machado R, MacKenzie Ross R, Moledina S, Montani D, Newnham M, Peacock A, Pepke-Zaba J, Rayner-Matthews P, Shamardina O, Soubrier F, Southgate L, Suntharalingam J, Toshner M, Trembath R, Vonk Noordegraaf A, Wilkins MR, Wort SJ, Wharton J; NIHR BioResource–Rare Diseases Consortium; UK National Cohort Study of Idiopathic and Heritable PAH, Gräf S, Morrell NW.

Circulation. 2017 Nov 21;136(21):2022-2033. doi: 10.1161/CIRCULATIONAHA.117.028351. Epub 2017 Sep 28.

27.

The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension.

Price LC, Dimopoulos K, Marino P, Alonso-Gonzalez R, McCabe C, Kemnpy A, Swan L, Boutsikou M, Al Zahrani A, Coghlan GJ, Schreiber BE, Howard LS, Davies R, Toshner M, Pepke-Zaba J, Church AC, Peacock A, Corris PA, Lordan JL, Gaine S, Condliffe R, Kiely DG, Wort SJ.

Thorax. 2017 Nov;72(11):1035-1045. doi: 10.1136/thoraxjnl-2016-209725. Epub 2017 Sep 12. Review.

PMID:
28904006
28.

Combining creative writing and narrative analysis to deliver new insights into the impact of pulmonary hypertension.

Goddard JC, Armstrong IJ, Kiely DG, Elliot CA, Charalampopoulos A, Condliffe R, Stone BJ, Sabroe I.

BMJ Open Respir Res. 2017 Jun 5;4(1):e000184. doi: 10.1136/bmjresp-2017-000184. eCollection 2017.

29.

Unmasking hidden disease: exercise pulmonary haemodynamics in systemic sclerosis.

Condliffe R.

Eur Respir J. 2017 Jul 13;50(1). pii: 1700885. doi: 10.1183/13993003.00885-2017. Print 2017 Jul. No abstract available.

30.

Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study.

Rhodes CJ, Wharton J, Ghataorhe P, Watson G, Girerd B, Howard LS, Gibbs JSR, Condliffe R, Elliot CA, Kiely DG, Simonneau G, Montani D, Sitbon O, Gall H, Schermuly RT, Ghofrani HA, Lawrie A, Humbert M, Wilkins MR.

Lancet Respir Med. 2017 Sep;5(9):717-726. doi: 10.1016/S2213-2600(17)30161-3. Epub 2017 Jun 15.

31.

Incremental shuttle walk test distance and autonomic dysfunction predict survival in pulmonary arterial hypertension.

Billings CG, Hurdman JA, Condliffe R, Elliot CA, Smith IA, Austin M, Armstrong IJ, Hamilton N, Charalampopoulos A, Sabroe I, Swift AJ, Rothman AM, Wild JM, Lawrie A, Waterhouse JC, Kiely DG.

J Heart Lung Transplant. 2017 Aug;36(8):871-879. doi: 10.1016/j.healun.2017.04.008. Epub 2017 Apr 24.

32.

The use of Macitentan in Fontan circulation: a case report.

Demetriades P, Aziz A, Condliffe R, Bowater SE, Clift PF.

BMC Cardiovasc Disord. 2017 May 22;17(1):131. doi: 10.1186/s12872-017-0567-5.

33.

Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension.

Swift AJ, Capener D, Johns C, Hamilton N, Rothman A, Elliot C, Condliffe R, Charalampopoulos A, Rajaram S, Lawrie A, Campbell MJ, Wild JM, Kiely DG.

Am J Respir Crit Care Med. 2017 Jul 15;196(2):228-239. doi: 10.1164/rccm.201611-2365OC.

34.

Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.

Ramjug S, Hussain N, Hurdman J, Billings C, Charalampopoulos A, Elliot CA, Kiely DG, Sabroe I, Rajaram S, Swift AJ, Condliffe R.

Chest. 2017 Jul;152(1):92-102. doi: 10.1016/j.chest.2017.02.010. Epub 2017 Feb 20.

PMID:
28223154
35.

Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry.

Sithamparanathan S, Nair A, Thirugnanasothy L, Coghlan JG, Condliffe R, Dimopoulos K, Elliot CA, Fisher AJ, Gaine S, Gibbs JSR, Gatzoulis MA, E Handler C, Howard LS, Johnson M, Kiely DG, Lordan JL, Peacock AJ, Pepke-Zaba J, Schreiber BE, Sheares KKK, Wort SJ, Corris PA; National Pulmonary Hypertension Service Research Collaboration of the United Kingdom and Ireland.

J Heart Lung Transplant. 2017 Jul;36(7):770-779. doi: 10.1016/j.healun.2016.12.014. Epub 2016 Dec 31.

PMID:
28190786
36.

Pathways for outpatient management of venous thromboembolism in a UK centre.

Condliffe R.

Thromb J. 2016 Dec 5;14:47. eCollection 2016. Review.

37.

Bosutinib therapy resulting in severe deterioration of pre-existing pulmonary arterial hypertension.

Hickey PM, Thompson AA, Charalampopoulos A, Elliot CA, Hamilton N, Kiely DG, Lawrie A, Sabroe I, Condliffe R.

Eur Respir J. 2016 Nov;48(5):1514-1516. doi: 10.1183/13993003.01004-2016. Epub 2016 Sep 22. No abstract available.

38.

Long-term outcomes of domiciliary intravenous iloprost in idiopathic and connective tissue disease-associated pulmonary arterial hypertension.

Ramjug S, Hussain N, Hurdman J, Elliot CA, Sabroe I, Armstrong IJ, Billings C, Hamilton N, Kiely DG, Condliffe R.

Respirology. 2017 Feb;22(2):372-377. doi: 10.1111/resp.12899. Epub 2016 Sep 20.

PMID:
27651181
39.

Pulmonary hypertension in patients with heart failure and preserved ejection fraction: differential diagnosis and management.

Hussain N, Charalampopoulos A, Ramjug S, Condliffe R, Elliot CA, O'Toole L, Swift A, Kiely DG.

Pulm Circ. 2016 Mar;6(1):3-14. doi: 10.1086/685021. Review.

40.

Effect of dual pulmonary vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease: a retrospective analysis.

Monfredi O, Heward E, Griffiths L, Condliffe R, Mahadevan VS.

Open Heart. 2016 Apr 15;3(1):e000399. doi: 10.1136/openhrt-2016-000399. eCollection 2016.

41.

Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort.

Cannon JE, Su L, Kiely DG, Page K, Toshner M, Swietlik E, Treacy C, Ponnaberanam A, Condliffe R, Sheares K, Taboada D, Dunning J, Tsui S, Ng C, Gopalan D, Screaton N, Elliot C, Gibbs S, Howard L, Corris P, Lordan J, Johnson M, Peacock A, MacKenzie-Ross R, Schreiber B, Coghlan G, Dimopoulos K, Wort SJ, Gaine S, Moledina S, Jenkins DP, Pepke-Zaba J.

Circulation. 2016 May 3;133(18):1761-71. doi: 10.1161/CIRCULATIONAHA.115.019470. Epub 2016 Apr 6.

42.

Pulmonary arterial hypertension associated with congenital heart disease: Comparison of clinical and anatomic-pathophysiologic classification.

Ramjug S, Hussain N, Hurdman J, Billings C, Charalampopoulos A, Elliot CA, Sabroe I, Kiely DG, Condliffe R.

J Heart Lung Transplant. 2016 May;35(5):610-8. doi: 10.1016/j.healun.2015.12.016. Epub 2016 Jan 7.

PMID:
26880324
43.

Pulmonary artery denervation reduces pulmonary artery pressure and induces histological changes in an acute porcine model of pulmonary hypertension.

Rothman AM, Arnold ND, Chang W, Watson O, Swift AJ, Condliffe R, Elliot CA, Kiely DG, Suvarna SK, Gunn J, Lawrie A.

Circ Cardiovasc Interv. 2015 Nov;8(11):e002569. doi: 10.1161/CIRCINTERVENTIONS.115.002569.

44.

Management of acute pulmonary embolism.

Quadery R, Elliot CA, Hurdman J, Kiely DG, Maclean RM, Sabroe I, van Veen JJ, Condliffe R.

Br J Hosp Med (Lond). 2015 Oct;76(10):C150-5. doi: 10.12968/hmed.2015.76.10.C150. No abstract available.

PMID:
26457952
45.

Longitudinal and transverse right ventricular function in pulmonary hypertension: cardiovascular magnetic resonance imaging study from the ASPIRE registry.

Swift AJ, Rajaram S, Capener D, Elliot C, Condliffe R, Wild JM, Kiely DG.

Pulm Circ. 2015 Sep;5(3):557-64. doi: 10.1086/682428.

46.

Right ventricular sex differences in patients with idiopathic pulmonary arterial hypertension characterised by magnetic resonance imaging: pair-matched case controlled study.

Swift AJ, Capener D, Hammerton C, Thomas SM, Elliot C, Condliffe R, Wild JM, Kiely DG.

PLoS One. 2015 May 21;10(5):e0127415. doi: 10.1371/journal.pone.0127415. eCollection 2015.

47.

Elevated plasma CXCL12α is associated with a poorer prognosis in pulmonary arterial hypertension.

McCullagh BN, Costello CM, Li L, O'Connell C, Codd M, Lawrie A, Morton A, Kiely DG, Condliffe R, Elliot C, McLoughlin P, Gaine S.

PLoS One. 2015 Apr 9;10(4):e0123709. doi: 10.1371/journal.pone.0123709. eCollection 2015.

48.

Connective tissue disease-associated pulmonary arterial hypertension.

Condliffe R, Howard LS.

F1000Prime Rep. 2015 Jan 5;7:06. doi: 10.12703/P7-06. eCollection 2015. Review.

49.

[Definitions and diagnosis of pulmonary hypertension].

Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, Langleben D, Manes A, Satoh T, Torres F, Wilkins MR, Badesch DB.

Turk Kardiyol Dern Ars. 2014 Oct;42 Suppl 1:55-66. Turkish.

50.

CT features of pulmonary arterial hypertension and its major subtypes: a systematic CT evaluation of 292 patients from the ASPIRE Registry.

Rajaram S, Swift AJ, Condliffe R, Johns C, Elliot CA, Hill C, Davies C, Hurdman J, Sabroe I, Wild JM, Kiely DG.

Thorax. 2015 Apr;70(4):382-7. doi: 10.1136/thoraxjnl-2014-206088. Epub 2014 Dec 18.

Supplemental Content

Loading ...
Support Center